The Jonas Webb Building
Babraham Research Campus
Tel: 44 1223 804200
Fax: 44 1223 804210
26 articles with Sphere Fluidics
7/23/2020Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
Sphere Fluidics and Heriot-Watt University Collaborate to Develop Next Generation Droplet Generator Instrumentation
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, and Heriot-Watt University, a specialist, pioneering Scottish University, announced they have been awarded a Knowledge Transfer Partnership grant from Innovate UK, the UK’s innovation agency.
4/23/2020Biopharma and life sciences groups from across the globe provide updates on their business and pipelines.
Single cell analysis for therapeutic discovery recognized with prestigious business award for innovation
Sphere Fluidics Expands Commercial Operations to Increase Supply of Pico-Surf Surfactant for Droplet Microfluidics
Sphere Fluidics announced investment in the production and supply of its proprietary biocompatible surfactant, Pico-Surf™, for reliable and highly stable droplet generation and processing.
11/7/2019Biotech and pharmaceutical companies from across the globe provide updates on their business and pipelines.
Sphere Fluidics and Peak Analysis and Automation Introduce Integrated Micro-plate Handling and Single Cell Analysis Capabilities
Integration of PAA’s S-LAB with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System increases throughput in antibody discovery and cell line development
Sphere Fluidics introduced the Cyto-Cellect™ Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell line development.
8/22/2019Companies from across the globe provide updates on their business and pipelines.
6/13/2019Companies from across the globe share business and pipeline updates.
Sphere Fluidics announced that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment.
3/29/2019Biotech and pharma companies bring on new talent to strengthen leadership teams and boards.
Rob Treanor joins as Director of Operations and Andrew Campbell as Director of Finance
It’s no secret that the global biopharma and life sciences industry is large. Sometimes the immense size of the industry can lead fascinating news tidbits to fall through the cracks, particularly those from smaller companies scattered across the globe. This week BioSpace will launch a new roundup...
Investment received from Greenwood Way Capital, Oxford Technology and Innovations EIS Fund and 24Haymarket
Sphere Fluidics Collaborates with Peak Analysis and Automation to Increase Throughput in Antibody Discovery and Cell Line Development
PAA’s S-LAB micro-plate handling capability will be integrated with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System
Sphere Fluidics today introduced Cyto-Mine® Studio Software Suite, an updated software for its innovative Cyto-Mine Single Cell Analysis System.
8/20/2018This past week’s roundup of Movers and Shakers in the biotech industry started with a surprise. Gilead Science’s new(ish) chief medical officer was leaving the company six months after taking over the position.
Sphere Fluidics announced today that Tris Vaughan, PhD FRSB has joined its scientific advisory board (SAB).
The Company is expanding its direct sales and support activity in North America, having recently opened a sales and support operation in New Jersey, and has established a network of distributors in Europe and the Far East to support the launch of its integrated Cyto-Mine Single Cell Analysis System.